Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam plus alfentanil dose comparison versus propofol plus alfentanil for painless pediatric gastroscopy
ChiCTR2300076282Phase 4Recruiting
- Sponsor
- Gansu Provincial Maternity and Child Care Hospital
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, alfentanil and propofol (4 arms), sponsored by Gansu Provincial Maternity and Child Care Hospital. Primary endpoints: Number of successful cases of sedation, Sedation onset time and 1 more. Started May 2023; status: recruiting.
02
Drugs
remimazolamalfentanilpropofol
Beyond the preview
Go deeper on ChiCTR2300076282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076282.